These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 27142108

  • 1. Design, Optimization and Evaluation of Orally Disintegrating Tablet of Meloxicam Using Its Menthol Based Solid Dispersions.
    Dehghani H, Taheri A, Homayouni A.
    Curr Drug Deliv; 2017; 14(5):709-717. PubMed ID: 27142108
    [Abstract] [Full Text] [Related]

  • 2. A pilot human pharmacokinetic study and influence of formulation factors on orodispersible tablet incorporating meloxicam solid dispersion using factorial design.
    Aboelwafa AA, Fahmy RH.
    Pharm Dev Technol; 2012; 17(1):1-14. PubMed ID: 20550483
    [Abstract] [Full Text] [Related]

  • 3. Formulation and Evaluation of Baclofen-Meloxicam Orally Disintegrating Tablets (ODTs) Using Co-Processed Excipients and Improvement of ODTs Performance Using Six Sigma Method.
    Abdelmonem R, Abdellatif MM, Al-Samadi IEI, El-Nabarawi MA.
    Drug Des Devel Ther; 2021; 15():4383-4402. PubMed ID: 34690500
    [Abstract] [Full Text] [Related]

  • 4. Microwave-Assisted Development of Orally Disintegrating Tablets by Direct Compression.
    Kande KV, Kotak DJ, Degani MS, Kirsanov D, Legin A, Devarajan PV.
    AAPS PharmSciTech; 2017 Aug; 18(6):2055-2066. PubMed ID: 27995465
    [Abstract] [Full Text] [Related]

  • 5. Formulation, in vitro characterization and optimization of taste-masked orally disintegrating co-trimoxazole tablet by direct compression.
    Tafere C, Yilma Z, Abrha S, Yehualaw A.
    PLoS One; 2021 Aug; 16(3):e0246648. PubMed ID: 33725014
    [Abstract] [Full Text] [Related]

  • 6. An optimized commercially feasible milling technique for molecular encapsulation of meloxicam in β-cyclodextrin.
    Bandarkar FS, Vavia PR.
    Drug Dev Ind Pharm; 2011 Nov; 37(11):1318-28. PubMed ID: 21506882
    [Abstract] [Full Text] [Related]

  • 7. Formulation and optimization of mouth dissolve tablets containing rofecoxib solid dispersion.
    Sammour OA, Hammad MA, Megrab NA, Zidan AS.
    AAPS PharmSciTech; 2006 Jun 16; 7(2):E55. PubMed ID: 16796372
    [Abstract] [Full Text] [Related]

  • 8. Fast and pH-dependent release of domperidone from orally disintegrating tablets.
    Assaf SM, Qandil AM, Al-Ani EA.
    Pharm Dev Technol; 2013 Jun 16; 18(4):897-905. PubMed ID: 22304659
    [Abstract] [Full Text] [Related]

  • 9. Design, development, and optimization of orally disintegrating tablets of etoricoxib using vacuum-drying approach.
    Patel D, Shah M, Shah S, Shah T, Amin A.
    PDA J Pharm Sci Technol; 2008 Jun 16; 62(3):224-32. PubMed ID: 18661871
    [Abstract] [Full Text] [Related]

  • 10. Further improvement of orally disintegrating tablets using micronized ethylcellulose.
    Okuda Y, Irisawa Y, Okimoto K, Osawa T, Yamashita S.
    Int J Pharm; 2012 Feb 28; 423(2):351-9. PubMed ID: 22138608
    [Abstract] [Full Text] [Related]

  • 11. Preparation and evaluation of swelling induced-orally disintegrating tablets by microwave irradiation.
    Sano S, Iwao Y, Kimura S, Itai S.
    Int J Pharm; 2011 Sep 15; 416(1):252-9. PubMed ID: 21763765
    [Abstract] [Full Text] [Related]

  • 12. Enhancement of Solubility of Lamotrigine by Solid Dispersion and Development of Orally Disintegrating Tablets Using 3(2) Full Factorial Design.
    Singh J, Garg R, Gupta GD.
    J Pharm (Cairo); 2015 Sep 15; 2015():828453. PubMed ID: 26634173
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Development and optimization of lyophilized orally disintegrating tablets using factorial design.
    Ahmed IS, Shamma RN, Shoukri RA.
    Pharm Dev Technol; 2013 Sep 15; 18(4):935-43. PubMed ID: 22107175
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Formulation of cyclodextrin inclusion complex-based orally disintegrating tablet of eslicarbazepine acetate for improved oral bioavailability.
    Desai S, Poddar A, Sawant K.
    Mater Sci Eng C Mater Biol Appl; 2016 Jan 01; 58():826-34. PubMed ID: 26478377
    [Abstract] [Full Text] [Related]

  • 20. Enhancement of the dissolution and permeation rates of meloxicam by formation of its freeze-dried solid dispersions in polyvinylpyrrolidone K-30.
    El-Badry M, Fathy M.
    Drug Dev Ind Pharm; 2006 Feb 01; 32(2):141-50. PubMed ID: 16537195
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.